» Articles » PMID: 39457068

Autism Spectrum Disorder Pathogenesis-A Cross-Sectional Literature Review Emphasizing Molecular Aspects

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Oct 26
PMID 39457068
Authors
Affiliations
Soon will be listed here.
Abstract

The etiology of autism spectrum disorder (ASD) has not yet been completely elucidated. Through time, multiple attempts have been made to uncover the causes of ASD. Different theories have been proposed, such as being caused by alterations in the gut-brain axis with an emphasis on gut dysbiosis, post-vaccine complications, and genetic or even autoimmune causes. In this review, we present data covering the main streams that focus on ASD etiology. Data collection occurred in many countries covering ethnically diverse subjects. Moreover, we aimed to show how the progress in genetic techniques influences the explanation of medical White Papers in the ASD area. There is no single evidence-based pathway that results in symptoms of ASD. Patient management has constantly only been symptomatic, and there is no ASD screening apart from symptom-based diagnosis and parent-mediated interventions. Multigene sequencing or epigenetic alterations hold promise in solving the disjointed molecular puzzle. Further research is needed, especially in the field of biogenetics and metabolomic aspects, because young children constitute the patient group most affected by ASD. In summary, to date, molecular research has confirmed multigene dysfunction as the causative factor of ASD, the multigene model with metabolomic influence would explain the heterogeneity in ASD, and it is proposed that ion channel dysfunction could play a core role in ASD pathogenesis.

Citing Articles

Calcium Signaling and Molecular Adhesion Processes May Hold the Key to Genetic Risk for Autism: A Molecular Pathway Analysis on Two Independent Samples.

Drago A, Calabro M, Crisafulli C Genes (Basel). 2025; 15(12.

PMID: 39766876 PMC: 11675254. DOI: 10.3390/genes15121609.

References
1.
Vicari S, Napoli E, Cordeddu V, Menghini D, Alesi V, Loddo S . Copy number variants in autism spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2019; 92:421-427. DOI: 10.1016/j.pnpbp.2019.02.012. View

2.
Ho L, Tong V, Syn N, Nagarajan N, Tham E, Tay S . Gut microbiota changes in children with autism spectrum disorder: a systematic review. Gut Pathog. 2020; 12:6. PMC: 6996179. DOI: 10.1186/s13099-020-0346-1. View

3.
Xu X, Li C, Gao X, Xia K, Guo H, Li Y . Excessive UBE3A dosage impairs retinoic acid signaling and synaptic plasticity in autism spectrum disorders. Cell Res. 2017; 28(1):48-68. PMC: 5752837. DOI: 10.1038/cr.2017.132. View

4.
Yui K, Imataka G, Yoshihara S . Lipid-Based Molecules on Signaling Pathways in Autism Spectrum Disorder. Int J Mol Sci. 2022; 23(17). PMC: 9456412. DOI: 10.3390/ijms23179803. View

5.
Durand C, Perroy J, Loll F, Perrais D, Fagni L, Bourgeron T . SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Mol Psychiatry. 2011; 17(1):71-84. PMC: 3252613. DOI: 10.1038/mp.2011.57. View